586 related articles for article (PubMed ID: 31244652)
1. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
Patnaik S; Anupriya
Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.
Li J; Chen C; Bi X; Zhou C; Huang T; Ni C; Yang P; Chen S; Ye M; Duan S
Gene; 2017 Sep; 630():1-7. PubMed ID: 28782576
[TBL] [Abstract][Full Text] [Related]
3. The role of epigenetic therapies in colorectal cancer.
Baretti M; Azad NS
Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiling of MUTYH, KLF6, WNT1 and KLF4 genes in carcinogenesis and tumorigenesis of colorectal cancer.
Babaei K; Khaksar R; Zeinali T; Hemmati H; Bandegi A; Samidoust P; Ashoobi MT; Hashemian H; Delpasand K; Talebinasab F; Naebi H; Mirpour SH; Keymoradzadeh A; Norollahi SE
Biomedicine (Taipei); 2019 Dec; 9(4):22. PubMed ID: 31724937
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Drug Therapy in the Treatment of Colorectal Cancer.
Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Seifi S; Parizadeh SMR; Moetamani-Ahmadi M; Hassanian SM; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Pharm Des; 2018; 24(23):2701-2709. PubMed ID: 30062956
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
[TBL] [Abstract][Full Text] [Related]
7. The role of epigenetic modifications in Colorectal Cancer Metastasis.
Su R; Wu X; Tao L; Wang C
Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
Castilho RM; Squarize CH; Almeida LO
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
Burgermeister E; Höde P; Betge J; Gutting T; Merkel A; Wu W; Tänzer M; Mossner M; Nowak D; Magdeburg J; Rückert F; Sticht C; Breitkopf-Heinlein K; Schulte N; Härtel N; Belle S; Post S; Gaiser T; Heppner BI; Behrens HM; Röcken C; Ebert MPA
Oncotarget; 2017 Oct; 8(49):84714-84728. PubMed ID: 29156678
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis.
Li Q; Chen H
Epigenetics; 2011 Jul; 6(7):849-52. PubMed ID: 21758003
[TBL] [Abstract][Full Text] [Related]
11. Targeting histone methylation for colorectal cancer.
Huang T; Lin C; Zhong LL; Zhao L; Zhang G; Lu A; Wu J; Bian Z
Therap Adv Gastroenterol; 2017 Jan; 10(1):114-131. PubMed ID: 28286564
[TBL] [Abstract][Full Text] [Related]
12. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
[TBL] [Abstract][Full Text] [Related]
13. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
14. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics and its therapeutic potential in colorectal cancer.
Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
[TBL] [Abstract][Full Text] [Related]
16. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
[TBL] [Abstract][Full Text] [Related]
18. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
